Related Experiment Video

Updated: Aug 13, 2026

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
03:19

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

Published on: June 28, 2024

Fetal fatty acid oxidation defects and maternal liver disease in pregnancy

Marsha F Browning1, Harvey L Levy, Louise E Wilkins-Haug

  • 1Harvard Medical School, Massachusetts General Hospital, Children's Hospital Boston, Brigham and Women's Hospital, MA 02114, USA. mfbrowning@partners.org

Obstetrics and Gynecology
|January 6, 2006
PubMed

Insights

Fetal fatty acid oxidation defects significantly increase the risk of maternal liver disease, including acute fatty liver of pregnancy and HELLP syndrome. This risk applies to all defect types, not just long-chain variants.

Area of Science:

  • Perinatal Medicine
  • Maternal-Fetal Medicine
  • Biochemistry

Background:

  • Fetal fatty acid oxidation defects are rare genetic disorders.
  • Maternal liver disease, such as acute fatty liver of pregnancy and HELLP syndrome, poses significant risks during pregnancy.

Purpose of the Study:

  • To investigate the association between all types of fetal fatty acid oxidation defects and maternal liver disease.
  • To compare the risk of maternal liver disease in pregnancies with different classifications of fetal fatty acid oxidation defects.

Main Methods:

  • A case-control study design was employed.
  • Fifty infants with fatty acid oxidation defects were compared to 1,250 matched controls.
  • Conditional logistic regression analysis was used to evaluate maternal liver disease outcomes.

Main Results:

  • Pregnancies with fetal fatty acid oxidation defects had a significantly higher incidence of maternal liver disease (16.00% vs. 0.88%).
  • An 18.1-fold increased risk of maternal liver disease was observed in affected pregnancies compared to controls.
  • Long-chain defects showed a 50-fold increased risk, while short and medium-chain defects showed a 12-fold increased risk of maternal liver disease.

Conclusions:

  • Maternal liver disease is significantly more prevalent in pregnancies with any type of fetal fatty acid oxidation defect.
  • Both long-chain and short/medium-chain fetal fatty acid oxidation defects pose a substantial risk for maternal liver disease.
  • Further research into the pathophysiology of these defects is crucial for improving maternal and fetal health outcomes.
Abstract

More Related Videos

Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes12:11

Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes

Published on: August 27, 2015

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy11:08

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy

Published on: March 13, 2014

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...